135 related articles for article (PubMed ID: 32474620)
1. dsDNA from extracellular vesicles (EVs) in adult AML.
Bernardi S; Zanaglio C; Farina M; Polverelli N; Malagola M; Russo D
Ann Hematol; 2021 May; 100(5):1355-1356. PubMed ID: 32474620
[No Abstract] [Full Text] [Related]
2. Evaluation of dsDNA from extracellular vesicles (EVs) in pediatric AML diagnostics.
Kontopoulou E; Strachan S; Reinhardt K; Kunz F; Walter C; Walkenfort B; Jastrow H; Hasenberg M; Giebel B; von Neuhoff N; Reinhardt D; Thakur BK
Ann Hematol; 2020 Mar; 99(3):459-475. PubMed ID: 31932899
[TBL] [Abstract][Full Text] [Related]
3. Transfer of multidrug resistance among acute myeloid leukemia cells via extracellular vesicles and their microRNA cargo.
Bouvy C; Wannez A; Laloy J; Chatelain C; Dogné JM
Leuk Res; 2017 Nov; 62():70-76. PubMed ID: 28987820
[TBL] [Abstract][Full Text] [Related]
4. MUC1-mediated induction of myeloid-derived suppressor cells in patients with acute myeloid leukemia.
Pyzer AR; Stroopinsky D; Rajabi H; Washington A; Tagde A; Coll M; Fung J; Bryant MP; Cole L; Palmer K; Somaiya P; Karp Leaf R; Nahas M; Apel A; Jain S; McMasters M; Mendez L; Levine J; Joyce R; Arnason J; Pandolfi PP; Kufe D; Rosenblatt J; Avigan D
Blood; 2017 Mar; 129(13):1791-1801. PubMed ID: 28126925
[TBL] [Abstract][Full Text] [Related]
5. Extracellular vesicles in leukemia.
Pando A; Reagan JL; Quesenberry P; Fast LD
Leuk Res; 2018 Jan; 64():52-60. PubMed ID: 29190514
[TBL] [Abstract][Full Text] [Related]
6. High serum extracellular vesicle miR-10b expression predicts poor prognosis in patients with acute myeloid leukemia.
Fang Z; Wang X; Wu J; Xiao R; Liu J
Cancer Biomark; 2020; 27(1):1-9. PubMed ID: 31594209
[TBL] [Abstract][Full Text] [Related]
7. Palmitoylated Proteins on AML-Derived Extracellular Vesicles Promote Myeloid-Derived Suppressor Cell Differentiation via TLR2/Akt/mTOR Signaling.
Tohumeken S; Baur R; Böttcher M; Stoll A; Loschinski R; Panagiotidis K; Braun M; Saul D; Völkl S; Baur AS; Bruns H; Mackensen A; Jitschin R; Mougiakakos D
Cancer Res; 2020 Sep; 80(17):3663-3676. PubMed ID: 32605996
[TBL] [Abstract][Full Text] [Related]
8. Disease dynamics in patients with acute myeloid leukemia: new biomarkers.
Tzoran I; Rebibo-Sabbah A; Brenner B; Aharon A
Exp Hematol; 2015 Nov; 43(11):936-43. PubMed ID: 26232698
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-155 in serum-derived extracellular vesicles as a potential biomarker for hematologic malignancies - a short report.
Caivano A; La Rocca F; Simeon V; Girasole M; Dinarelli S; Laurenzana I; De Stradis A; De Luca L; Trino S; Traficante A; D'Arena G; Mansueto G; Villani O; Pietrantuono G; Laurenti L; Del Vecchio L; Musto P
Cell Oncol (Dordr); 2017 Feb; 40(1):97-103. PubMed ID: 27761889
[TBL] [Abstract][Full Text] [Related]
10. High serum levels of extracellular vesicles expressing malignancy-related markers are released in patients with various types of hematological neoplastic disorders.
Caivano A; Laurenzana I; De Luca L; La Rocca F; Simeon V; Trino S; D'Auria F; Traficante A; Maietti M; Izzo T; D'Arena G; Mansueto G; Pietrantuono G; Laurenti L; Musto P; Del Vecchio L
Tumour Biol; 2015 Dec; 36(12):9739-52. PubMed ID: 26156801
[TBL] [Abstract][Full Text] [Related]
11. PML-RARa modulates the vascular signature of extracellular vesicles released by acute promyelocytic leukemia cells.
Fang Y; Garnier D; Lee TH; D'Asti E; Montermini L; Meehan B; Rak J
Angiogenesis; 2016 Jan; 19(1):25-38. PubMed ID: 26374632
[TBL] [Abstract][Full Text] [Related]
12. Impact of Bone Marrow miR-21 Expression on Acute Myeloid Leukemia T Lymphocyte Fragility and Dysfunction.
Moussa Agha D; Rouas R; Najar M; Bouhtit F; Fayyad-Kazan H; Lagneaux L; Bron D; Meuleman N; Lewalle P; Merimi M
Cells; 2020 Sep; 9(9):. PubMed ID: 32911844
[TBL] [Abstract][Full Text] [Related]
13. Functional transferred DNA within extracellular vesicles.
Cai J; Wu G; Jose PA; Zeng C
Exp Cell Res; 2016 Nov; 349(1):179-183. PubMed ID: 27751837
[TBL] [Abstract][Full Text] [Related]
14. Characteristics and Changes of DNA in Extracellular Vesicles.
Chang X; Fang L; Bai J; Wang Z
DNA Cell Biol; 2020 Sep; 39(9):1486-1493. PubMed ID: 32551866
[TBL] [Abstract][Full Text] [Related]
15. Procoagulant activity of extracellular vesicles as a potential biomarker for risk of thrombosis and DIC in patients with acute leukaemia.
Gheldof D; Haguet H; Dogné JM; Bouvy C; Graux C; George F; Sonet A; Chatelain C; Chatelain B; Mullier F
J Thromb Thrombolysis; 2017 Feb; 43(2):224-232. PubMed ID: 28074413
[TBL] [Abstract][Full Text] [Related]
16. PO-46 - Influence of extracellular vesicles derived from AML patients on stem cells and their microenvironment.
Tzoran I; Rebibo-Sabbah A; Brenner B; Aharon A
Thromb Res; 2016 Apr; 140 Suppl 1():S193. PubMed ID: 27161733
[TBL] [Abstract][Full Text] [Related]
17. Extracellular Vesicles and Chemotherapy Resistance in the AML Microenvironment.
Nehrbas J; Butler JT; Chen DW; Kurre P
Front Oncol; 2020; 10():90. PubMed ID: 32117744
[TBL] [Abstract][Full Text] [Related]
18. Detection of AML-specific mutations in pediatric patient plasma using extracellular vesicle-derived RNA.
Kunz F; Kontopoulou E; Reinhardt K; Soldierer M; Strachan S; Reinhardt D; Thakur BK
Ann Hematol; 2019 Mar; 98(3):595-603. PubMed ID: 30673813
[TBL] [Abstract][Full Text] [Related]
19. Role of Extracellular Vesicle Surface Proteins in the Pharmacokinetics of Extracellular Vesicles.
Charoenviriyakul C; Takahashi Y; Morishita M; Nishikawa M; Takakura Y
Mol Pharm; 2018 Mar; 15(3):1073-1080. PubMed ID: 29382201
[TBL] [Abstract][Full Text] [Related]
20. Association of Extracellular Membrane Vesicles with Cutaneous Wound Healing.
Than UTT; Guanzon D; Leavesley D; Parker T
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28468315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
